This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Erber Aktiengesellschaft. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Elisavet Kunz-Vekiru: Innovator in Enzymatic Detoxification
Introduction
Elisavet Kunz-Vekiru is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of enzymatic detoxification, particularly in relation to zearalenone, a mycotoxin that poses risks to health.
Latest Patents
Kunz-Vekiru holds a patent for a polypeptide designed for the enzymatic detoxification of zearalenone. This invention involves a monooxygenase that converts the keto group in position 7 of zearalenone into an ester group. The patent details that the monooxygenase is an amino acid sequence selected from a specific group, with functional variants exhibiting a sequence identity of at least 60% to 90%. This innovation is crucial for improving food safety and reducing the impact of harmful toxins.
Career Highlights
Elisavet Kunz-Vekiru is associated with Erber Aktiengesellschaft, a company known for its commitment to food safety and quality. Her work has positioned her as a key figure in the development of solutions to combat mycotoxin contamination.
Collaborations
Kunz-Vekiru collaborates with notable colleagues, including Juan Antonio Torres Acosta and Gerhard Adam. These partnerships enhance the research and development efforts within her field.
Conclusion
Elisavet Kunz-Vekiru's innovative work in enzymatic detoxification represents a significant advancement in food safety. Her contributions are vital for addressing the challenges posed by mycotoxins in the food supply.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile